News

FDA funding increased under Trump's budget for 2019 fiscal year while resource reductions take place for NIH.

The 10th anniversary of the Clinical Trials Transformative Initiative provided an opportunity for FDA officials to join with study sponsors and research experts to examine the policy achievements and plans for future efforts of improving clinical trials.

During the CROWN congress, there was discussion on CRO acquisition and consolidation, growing interest in the use of Blockchain technology in clinical trials, and new patient engagement methodologies.

In this interview, Jennifer Prichard, MD, Medical Monitor at Atlantic Research Group, and Hunter Walker, CTO at Atlantic Research Group will discuss challenges with existing medical monitoring processes, and how new technologies can help improve efficiency.

More recent ClinicalTrials.gov data indicate that the United States remains the central location for clinical trial activity.

An industry shift has led toward more insourcing and in-house resources to run trials.

An expert view on how sponsors can formalize the use of real-world data and generation of real-world evidence to drive critical insights.